Skip to main content
PMC home page
Sexually Transmitted Infections logoLink to Sexually Transmitted Infections
. 2001 Dec;77(6):409–412. doi: 10.1136/sti.77.6.409

Podophyllin office therapy against condyloma should be abandoned

G von Krogh 1, E Longstaff 1
PMCID: PMC1744412  PMID: 11714936

Abstract

Podophyllin, a crude plant extract with low efficacy, high toxicity, and a serious mutagenicity profile does not comply with the WHO guidelines for plant derived treatments and should be removed from clinical treatment protocols. Home treatment with pharmaceutical products based on podophyllotoxin—the purified, standardised active antiwart ingredient of podophyllin—represents safe and effective first line therapy for patients with anogenital warts.

Key Words: podophyllin; podophyllotoxin; condyloma therapy

Full Text

The Full Text of this article is available as a PDF (102.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bjeldanes L. F., Chang G. W. Mutagenic activity of quercetin and related compounds. Science. 1977 Aug 5;197(4303):577–578. doi: 10.1126/science.327550. [DOI] [PubMed] [Google Scholar]
  2. Cassidy D. E., Drewry J., Fanning J. P. Podophyllum toxicity: a report of a fatal case and a review of the literature. J Toxicol Clin Toxicol. 1982 Mar;19(1):35–44. doi: 10.3109/15563658208990364. [DOI] [PubMed] [Google Scholar]
  3. Claesson U., Lassus A., Happonen H., Hogström L., Siboulet A. Topical treatment of venereal warts: a comparative open study of podophyllotoxin cream versus solution. Int J STD AIDS. 1996 Oct;7(6):429–434. doi: 10.1258/0956462961918400. [DOI] [PubMed] [Google Scholar]
  4. Dobb G. J., Edis R. H. Coma and neuropathy after ingestion of herbal laxative containing podophyllin. Med J Aust. 1984 Apr 14;140(8):495–496. doi: 10.5694/j.1326-5377.1984.tb108174.x. [DOI] [PubMed] [Google Scholar]
  5. Edwards A., Atma-Ram A., Thin R. N. Podophyllotoxin 0.5% v podophyllin 20% to treat penile warts. Genitourin Med. 1988 Aug;64(4):263–265. doi: 10.1136/sti.64.4.263. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Ferguson L. R., Pearson A. Chromosomal changes in Chinese hamster AA8 cells caused by podophyllin, a common treatment for genital warts. Mutat Res. 1992 Apr;266(2):231–239. doi: 10.1016/0027-5107(92)90191-4. [DOI] [PubMed] [Google Scholar]
  7. Filley C. M., Graff-Richard N. R., Lacy J. R., Heitner M. A., Earnest M. P. Neurologic manifestations of podophyllin toxicity. Neurology. 1982 Mar;32(3):308–311. doi: 10.1212/wnl.32.3.308. [DOI] [PubMed] [Google Scholar]
  8. Greenberg M. D., Rutledge L. H., Reid R., Berman N. R., Precop S. L., Elswick R. K., Jr A double-blind, randomized trial of 0.5% podofilox and placebo for the treatment of genital warts in women. Obstet Gynecol. 1991 May;77(5):735–739. [PubMed] [Google Scholar]
  9. Heath A., Mellstrand T., Ahlmén J. Treatment of podophyllin poisoning with resin hemoperfusion. Hum Toxicol. 1982 Oct;1(4):373–378. doi: 10.1177/096032718200100402. [DOI] [PubMed] [Google Scholar]
  10. KELLY M., HARTWELL J. L. The biological effects and the chemical composition of podophyllin: a review. J Natl Cancer Inst. 1954 Feb;14(4):967–1010. [PubMed] [Google Scholar]
  11. Kirby P., Dunne A., King D. H., Corey L. Double-blind randomized clinical trial of self-administered podofilox solution versus vehicle in the treatment of genital warts. Am J Med. 1990 May;88(5):465–469. doi: 10.1016/0002-9343(90)90424-c. [DOI] [PubMed] [Google Scholar]
  12. Lassus A. Comparison of podophyllotoxin and podophyllin in treatment of genital warts. Lancet. 1987 Aug 29;2(8557):512–513. doi: 10.1016/s0140-6736(87)91823-x. [DOI] [PubMed] [Google Scholar]
  13. Lund O., Marstrander J., Smeby B., Monstad I., Gadeholt G. Podofyllin. Systemisk forgiftning etter intrakutan injeksjon av fotvorter. Tidsskr Nor Laegeforen. 1988 Jun 10;108(16):1293–1294. [PubMed] [Google Scholar]
  14. Pamukcu A. M., Yalçiner S., Hatcher J. F., Bryan G. T. Quercetin, a rat intestinal and bladder carcinogen present in bracken fern (Pteridium aquilinum). Cancer Res. 1980 Oct;40(10):3468–3472. [PubMed] [Google Scholar]
  15. Petersen C. S., Weismann K. Quercetin and kaempherol: an argument against the use of podophyllin? Genitourin Med. 1995 Apr;71(2):92–93. doi: 10.1136/sti.71.2.92. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Sabine J. R., Horton B. J., Wicks M. B. Spontaneous tumors in C3H-A vy and C3H-A vy fB mice: high incidence in the United States and low incidence in Australia. J Natl Cancer Inst. 1973 May;50(5):1237–1242. doi: 10.1093/jnci/50.5.1237. [DOI] [PubMed] [Google Scholar]
  17. Savel H. The metaphase-arresting plant alkaloids and cancer chemotherapy. Prog Exp Tumor Res. 1966;8:189–224. doi: 10.1159/000386008. [DOI] [PubMed] [Google Scholar]
  18. Strand A., Brinkeborn R. M., Siboulet A. Topical treatment of genital warts in men, an open study of podophyllotoxin cream compared with solution. Genitourin Med. 1995 Dec;71(6):387–390. doi: 10.1136/sti.71.6.387. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Strauss M. J., Khanna V., Koenig J. D., Downs S. M., Goldberg S. H., Manyak M. J., Patsner B. The cost of treating genital warts. Int J Dermatol. 1996 May;35(5):340–348. doi: 10.1111/j.1365-4362.1996.tb03635.x. [DOI] [PubMed] [Google Scholar]
  20. Tomczak R. L., Hake D. H. Near fatal systemic toxicity from local injection of podophyllin for pedal verrucae treatment. J Foot Surg. 1992 Jan-Feb;31(1):36–42. [PubMed] [Google Scholar]
  21. West W. M., Ridgeway N. A., Morris A. J., Sides P. J. Fatal podophyllin ingestion. South Med J. 1982 Oct;75(10):1269–1270. doi: 10.1097/00007611-198210000-00031. [DOI] [PubMed] [Google Scholar]
  22. von Krogh G., Horenblas S. The management and prevention of premalignant penile lesions. Scand J Urol Nephrol Suppl. 2000;(205):220–229. doi: 10.1080/00365590050509959. [DOI] [PubMed] [Google Scholar]
  23. von Krogh G., Lacey C. J., Gross G., Barrasso R., Schneider A. European course on HPV associated pathology: guidelines for primary care physicians for the diagnosis and management of anogenital warts. Sex Transm Infect. 2000 Jun;76(3):162–168. doi: 10.1136/sti.76.3.162. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. von Krogh G., Maibach H. I. Guinea pig maximization test: Podophyllum lignans. Contact Dermatitis. 1983 Mar;9(2):95–98. doi: 10.1111/j.1600-0536.1983.tb04313.x. [DOI] [PubMed] [Google Scholar]
  25. von Krogh G. Penile condylomata acuminata: an experimental model for evaluation of topical self-treatment with 0.5--1.0% ethanolic preparations of podophyllotoxin for three days. Sex Transm Dis. 1981 Jul-Sep;8(3):179–186. [PubMed] [Google Scholar]
  26. von Krogh G. Podophyllotoxin for condylomata acuminata eradication. Clinical and experimental comparative studies on Podophyllum lignans, colchicine and 5-fluorouracil. Acta Derm Venereol Suppl (Stockh) 1981;98:1–48. [PubMed] [Google Scholar]
  27. von Krogh G. Podophyllotoxin in serum: absorption subsequent to three-day repeated applications of a 0.5% ethanolic preparation on condylomata acuminata. Sex Transm Dis. 1982 Jan-Mar;9(1):26–33. [PubMed] [Google Scholar]

Articles from Sexually Transmitted Infections are provided here courtesy of BMJ Publishing Group

RESOURCES